Stockreport

ImmunityBio GAAP EPS of -$0.06, revenue of $38.2M [Seeking Alpha]

ImmunityBio, Inc.  (IBRX) 
PDF Full-Year Net Product Revenue $113M ~700% Unit Sales Volume ~750% Q4 2025 Net Product Revenue $38.3M Click to enlarge Cash and Marketable Securities Pos [Read more]